6.7 C
New York
Friday, December 3, 2021
- Advertisement -spot_img

TAG

covid-19

ACI [NASDAQ: ACIW] Introduces its Proprietary Network Intelligence Technology

ACI Worldwide, Inc. disclosed that it has introduced its proprietary Network Intelligence Technology as an essential part of ACI Fraud Management. The new...

Sun Country [NASDAQ: SNCY] Ink Pact with Major League Soccer

Sun Country Airlines Holdings, Inc. inked a new five-year agreement to offer charter service to all Major League Soccer (MLS) teams. The agreement...

Rockwell [NYSE: ROK] Announces Strategic Agreement with The Pyure Company

Rockwell Automation, Inc. disclosed that it has entered into a five-year strategic agreement with The Pyure Company. The strategic agreement will enable the...

Why Ocugen [NASDAQ: OCGN] Stock Soaring Today?

Share of Ocugen, Inc. skyrocketed 5% during the trading session of Wednesday. The firm disclosed that it has filed an IND with the...

Clarivate [NYSE: CLVT] Launch Report Examining Research Performance of the World’s Leading Economies

Clarivate Plc has shared a new report which analyzes the research performance of each of the member countries of the G20 with a...

NRx [NASDAQ: NRXP] Gains 42% after Sharing Aviptadil Data in Critical COVID-19

NRx Pharmaceuticals, Inc. has shared the peer-reviewed results from a prospective, open-label, administratively controlled study of Aviptadil for the cure of respiratory failure...

Immuron [NASDAQ: IMRN] Shares Antiviral Benefits of IMM-124E

Immuron Limited has shared the potential antiviral benefits of IMM-124E in a mouse model and human clinical study in a contemporary statement. IMRN...

Humanigen [NASDAQ: HGEN] Announces Pact with Clinigen for Lenzilumab Managed Access Program

Humanigen, Inc. has inked a pact with Clinigen Group plc (Clinigen) to implement a Managed Access Program for lenzilumab (LenzMAP). LenzMAP will offer...

Moderna [NASDAQ: MRNA] Decides to Establish State-of-the-Art mRNA Facility in Africa

Moderna, Inc disclosed that it has decided to establish a sophisticated mRNA Facility in Africa. The firm has set a goal of producing...

CureVac [NASDAQ: CVAC] COVID-19 Vaccine Candidate Passes First Interim Analysis

CureVac N.V disclosed that its COVID-19 vaccine candidate which is known as CVnCoV has passed a first interim analysis at 59 adjudicated COVID-19...

Latest news

- Advertisement -spot_img